XML 47 R72.htm IDEA: XBRL DOCUMENT v3.19.3
Derivative Instruments, Hedging Activities and Fair Value Measurements, Recurring Fair Value Measurements (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Total gains (losses) included in:                  
Unrealized gain (loss) recognized as a component of net income related to financial assets and liabilities $ (85.8)     $ 204.1     $ (2.0) $ (254.9)  
Fair Value, Measurements, Recurring [Member]                  
Financial assets [Abstract]                  
Value before application of CME Rule 814 433.9           433.9   $ 456.9
Impact of CME Rule 814 (261.3)           (261.3)   (295.0)
Total commodity derivatives 172.6           172.6   161.9
Total 172.6           172.6   161.9
Financial liabilities [Abstract]                  
Liquidity option agreement 513.1           513.1   390.0
Interest rate derivatives 118.6           118.6    
Commodity derivatives:                  
Value before application of CME Rule 814 356.0           356.0   398.1
Impact of CME Rule 814 (205.5)           (205.5)   (235.7)
Total commodity derivatives 150.5           150.5   162.4
Total 782.2           782.2   552.4
Net value before application of CME Rule 814 to commodity hedging portfolio 77.9           77.9    
Fair Value, Measurements, Recurring [Member] | Level 1 [Member]                  
Financial assets [Abstract]                  
Value before application of CME Rule 814 54.0           54.0   172.3
Impact of CME Rule 814 (44.8)           (44.8)   (134.8)
Total commodity derivatives 9.2           9.2   37.5
Total 9.2           9.2   37.5
Financial liabilities [Abstract]                  
Liquidity option agreement 0.0           0.0   0.0
Interest rate derivatives 0.0           0.0    
Commodity derivatives:                  
Value before application of CME Rule 814 39.8           39.8   85.5
Impact of CME Rule 814 (31.0)           (31.0)   (48.6)
Total commodity derivatives 8.8           8.8   36.9
Total 8.8           8.8   36.9
Fair Value, Measurements, Recurring [Member] | Level 2 [Member]                  
Financial assets [Abstract]                  
Value before application of CME Rule 814 365.4           365.4   282.4
Impact of CME Rule 814 (206.3)           (206.3)   (159.3)
Total commodity derivatives 159.1           159.1   123.1
Total 159.1           159.1   123.1
Financial liabilities [Abstract]                  
Liquidity option agreement 0.0           0.0   0.0
Interest rate derivatives 118.6           118.6    
Commodity derivatives:                  
Value before application of CME Rule 814 268.3           268.3   291.2
Impact of CME Rule 814 (138.5)           (138.5)   (172.9)
Total commodity derivatives 129.8           129.8   118.3
Total 248.4           248.4   118.3
Fair Value, Measurements, Recurring [Member] | Level 3 [Member]                  
Financial assets [Abstract]                  
Value before application of CME Rule 814 14.5           14.5   2.2
Impact of CME Rule 814 (10.2)           (10.2)   (0.9)
Total commodity derivatives 4.3           4.3   1.3
Total 4.3           4.3   1.3
Financial liabilities [Abstract]                  
Liquidity option agreement 513.1           513.1   390.0
Interest rate derivatives 0.0           0.0    
Commodity derivatives:                  
Value before application of CME Rule 814 47.9           47.9   21.4
Impact of CME Rule 814 (36.0)           (36.0)   (14.2)
Total commodity derivatives 11.9           11.9   7.2
Total 525.0           525.0   $ 397.2
Reconciliation of changes in the fair value of Level 3 financial assets and liabilities [Roll Forward]                  
Financial liability balance, net, beginning of period (479.6) $ (446.9) $ (395.9) (349.0) $ (341.9) $ (332.7) (395.9) (332.7)  
Total gains (losses) included in:                  
Transfers out of Level 3 0.0 0.0 (0.2) 0.0 0.0 0.0      
Financial liability balance, net, end of period (520.7) (479.6) (446.9) (366.2) (349.0) (341.9) (520.7) (366.2)  
Unrealized gain (loss) recognized as a component of net income related to financial assets and liabilities 0.8     (1.5)     $ 0.6 $ (1.4)  
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Revenue [Member]                  
Total gains (losses) included in:                  
Net income [1] 0.8 (0.1) 3.1 (0.2) 1.3 (0.5)      
Settlements [1] 0.0 (3.1) (0.1) (1.3) 0.5 (1.2)      
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Other Expense [Member]                  
Total gains (losses) included in:                  
Net income (38.7) (26.6) (57.8) (18.5) (8.9) (7.5)      
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Other Comprehensive Income (Loss) [Member]                  
Total gains (losses) included in:                  
Other comprehensive income $ (3.2) $ (2.9) $ 4.0 $ 2.8 $ 0.0 $ 0.0      
[1]
There were $0.8 million and $0.6 million of unrealized gains included in these amounts for the three and nine months ended September 30, 2019, respectively.  There were unrealized losses of $1.5 million and $1.4 million, respectively, included in these amounts for the three and nine months ended September 30, 2018.